Copyright Pretorius et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Incremental cost-effectiveness ratio of PrEP: (incremental cost of PrEP)/(additional infections averted due to PrEP).
Baseline incidence 0.5% per year at 2025. Contours in intervals of $10,000. Contours above $50,000 are grayed out.